Alzheimer's Disease International (ADI) is the international federation of 77 Alzheimer associations around the world, in official relations with the World Health Organization. Each member is the national Alzheimer association in their country who support people with dementia and their families. ADI's mission is to improve the quality of life of people with dementia and their families throughout the world.
We work to strengthen our member organisations with materials and publications as well as continued practical and financial support so they are better able to meet the needs of people with dementia and their carers.
ADI was established in 1984 with 4 founding members. 23 years later ADI is now an internationally recognised organisation with a range of activities and events.
ADI holds an annual international conference which is the longest running international conference on dementia. The conference is a unique multi-disciplinary event which unites people with an interest in dementia from around the world.
ADI also runs the Alzheimer University, a series of practical workshops aimed at helping staff and volunteers of Alzheimer Associations build and strengthen capacity and develop their organisations.
World Alzheimer's Day, celebrated on September 21 each year, was launched in 1994 with support from the World Health Organisation. It is an opportunity to raise global awareness about dementia and its impact on families and the important work of our members throughout the world. ADI coordinates World Alzheimer's Day and provides members with materials to help them organise their own events.
ADI supports the 10/66 Dementia Research Group. This group gets its name from the fact that less than 10% of all population based research into dementia is directed towards the 66% or more of all people with dementia who live in developing countries. The network is made up of 100 active researchers from 32 developing countries that are studying the prevalence and impact of dementia in communities where it has not been studied before. The group has had its work published in leading journals including the Lancet, and presented study findings at major international conferences.